Veronica Byfield Sköld

Chief Executive Officer at BioLamina AB

Consumer Services

Health Technology

Consumer Non-Durables

Profile

Veronica Byfield Sköld is currently the Chief Executive Officer at BioLamina AB.
Previously, she worked as the Chief Sales Officer at Clemondo Group AB.
She holds a graduate degree from the Royal Institute of Technology and an undergraduate degree from IHM Business School AB.

Veronica Byfield Sköld active positions

Companies	Position	Start
BioLamina AB BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden.	Chief Executive Officer	01/10/2021

All active positions of Veronica Byfield Sköld

Former positions of Veronica Byfield Sköld

Companies	Position	End
CLEMONDO GROUP AB	Sales & Marketing	-

See the detail of Veronica Byfield Sköld's experience

Training of Veronica Byfield Sköld

Royal Institute of Technology	Graduate Degree
IHM Business School AB	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Veronica Byfield Sköld's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CLEMONDO GROUP AB	Consumer Non-Durables

Private companies	1
BioLamina AB BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden.	Health Technology